Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

艾可宁 - NMPA Drug Approval Details

Approvals/NMPA/Albuvirtide for Injection

Approved

化学药品

Albuvirtide for Injection

前沿生物药业（南京）股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 8, 2022
Approval ID: 7ucZuRIF9O7
Company: 前沿生物药业（南京）股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7ucZuRIF9O7
Approval Number: 国药准字H20180006
Generic Name: 注射用艾博韦泰
Generic Name En: Albuvirtide for Injection
Trade Name: 艾可宁
Brand Name: 艾可宁
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 160mg(以C₂₀₄H₃₀₆N₅₄O₇₂计)
Reg Date: 2022-12-08
Company Name: 前沿生物药业（南京）股份有限公司
Company Address: 南京市江宁区科学园乾德路5号7号楼（紫金方山）
Production Company Name: 海南双成药业股份有限公司;前沿生物药业(南京)股份有限公司
Production Company Address: 海口市秀英区兴国路16号；南京市江宁区科学园乾德路5号7号楼（紫金方山）；南京市江宁区至道路8号
Company Detail Path: /organization/35654b93282071a3/frontier-biotechnologies-inc

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 8, 2022

Approval ID

7ucZuRIF9O7

Type

化学药品

Back to NMPA Approvals